Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$404.2 MLN
01/04/2021 02:56
April 1 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* FY LOSS ATTRIBUTABLE HK$404.2 MILLION VERSUS LOSS OF
HK$395
MILLION
Source text for Eikon: ID:nHKS4qPQwg
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital